Who are HSPPC-96 or Oncophage's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/hsppc-96-or-oncophage.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

HSPPC-96 or Oncophage — Competitive Intelligence Brief

HSPPC-96 or Oncophage (HSPPC-96 or Oncophage) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Autologous therapeutic cancer vaccine. Area: Oncology.

phase 3 Autologous therapeutic cancer vaccine Tumor-associated antigens presented via Hsp96 complexes Oncology Small molecule Live · refreshed every 30 min

Target snapshot

HSPPC-96 or Oncophage (HSPPC-96 or Oncophage) — Agenus Inc.. HSPPC-96 is a personalized cancer vaccine that uses heat shock protein-peptide complexes derived from a patient's own tumor to stimulate immune recognition and destruction of cancer cells.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
HSPPC-96 or Oncophage TARGET	HSPPC-96 or Oncophage	Agenus Inc.	phase 3	Autologous therapeutic cancer vaccine	Tumor-associated antigens presented via Hsp96 complexes

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Autologous therapeutic cancer vaccine class)

Agenus Inc. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). HSPPC-96 or Oncophage — Competitive Intelligence Brief. https://druglandscape.com/ci/hsppc-96-or-oncophage. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab